The analysis for identifying large DNA fragment aberrations of MSH2 and MLH1 genes from familial colorectal cancer in China.
Ming Zhu(AbbVie (United States)), Yaping Wang(Southern Medical University), Yanqin Huang(Zhejiang University), Jintian Li(South China Normal University), Yuanying Zhang(University of Science and Technology Beijing), Xiaomei Zhang(Peking University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Ying Yuan(Zhejiang Cancer Hospital)
PubMed
December 1, 2005
Cited by 2
Related Papers
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|The Lancet Oncology|2017|327
GWASdb: a database for human genetic variants identified by genome-wide association studies
|Nucleic Acids Research|2011|233